Atossa refiles for IPO

Atossa Genetics Inc. (Seattle, Wash.) refiled for an IPO and hopes to sell up to 3 million units at $5-$7 in an offering underwritten by Dawson James Securities on the NYSE Amex. Each unit comprises a share, two 10-day warrants and a five-year warrant. In July, the company withdrew its IPO to raise up to $15 million on the OTC Bulletin Board. ...